Patent · US Active

Methods for assessing risk of developing a viral disease using a genetic test

US12241125B2 · kind B2 · utility

0Cited by

85References

30Claims

0Family size

Assignees

PML Screening, LLC · US
UNIVERSITE PARIS-SACLAY
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Eli Hatchwell · Smithtown, US
Peggy S. Eis · Fitchburg, US
Edward B. Smith, III · Seattle, US
Yassine Taoufik · Paris, FR

Key dates

Filing date	Apr 25, 2024
Grant date	Mar 4, 2025
Priority date	—
Expiry date	Apr 25, 2044

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.